Insulet (PODD) Change in Accured Expenses (2010 - 2026)

Insulet has reported Change in Accured Expenses for 17 years, with the latest figure at -$69.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 42.59% year-over-year to -$69.3 million; the trailing twelve-month figure through Mar 2026 stood at $140.5 million (up 109.08% YoY), and the FY2025 full-year result was $161.2 million, up 201.87% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$69.3 million, down from $78.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $84.2 million in Q3 2025, with the low at -$69.3 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged $16.2 million across 5 years, with a median of $21.6 million in 2024.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses jumped 16633.33% — and 2024, when it plunged 10300.0%.
• Insulet's Change in Accured Expenses stood at $46.1 million in 2022, then plunged by 109.11% to -$4.2 million in 2023, then jumped by 614.29% to $21.6 million in 2024, then surged by 261.11% to $78.0 million in 2025, then tumbled by 188.85% to -$69.3 million in 2026.
• The last three Change in Accured Expenses figures came in at -$69.3 million (Q1 2026), $78.0 million (Q4 2025), and $84.2 million (Q3 2025), per Business Quant data.